52 related articles for article (PubMed ID: 26670780)
1. Comparative studies on glycerol monooleate- and phytantriol-based cubosomes containing oridonin in vitro and in vivo.
Shi X; Peng T; Huang Y; Mei L; Gu Y; Huang J; Han K; Li G; Hu C; Pan X; Wu C
Pharm Dev Technol; 2017 May; 22(3):322-329. PubMed ID: 26670780
[TBL] [Abstract][Full Text] [Related]
2. Verapamil-Loaded Cubosomes for Enhancing Intranasal Drug Delivery: Development, Characterization, Ex Vivo Permeation, and Brain Biodistribution Studies.
Faisal MM; Gomaa E; Ibrahim AE; El Deeb S; Al-Harrasi A; Ibrahim TM
AAPS PharmSciTech; 2024 May; 25(5):95. PubMed ID: 38710921
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Application of a pH-Responsive Functional Metal-Organic Framework: In Vitro Investigation for Delivery of Oridonin in Cancer Therapy.
Shen J; Gao F; Pan Q; Zong Z; Liang L
Molecules; 2024 Jun; 29(11):. PubMed ID: 38893518
[TBL] [Abstract][Full Text] [Related]
4. Development, optimization and characterization of cisplatin loaded cubosomes for human lung carcinoma.
Umar H; Wahab HA; Ahmed N; Fujimura NA; Amjad MW; Bukhari SNA; Ahmad W
Drug Dev Ind Pharm; 2024 Mar; ():1-14. PubMed ID: 38451066
[TBL] [Abstract][Full Text] [Related]
5. Vesicular approach of cubosomes, its components, preparation techniques, evaluation and their appraisal for targeting cancer cells.
Iqbal S; Zaman M; Waqar MA; Sarwar HS; Jamshaid M
J Liposome Res; 2024 Jun; 34(2):368-384. PubMed ID: 37873797
[TBL] [Abstract][Full Text] [Related]
6. Oridonin loaded peptide nanovesicles alleviate nonalcoholic fatty liver disease in mice.
Zhang L; Yu Y; Wang Q; Huang X; Feng Z; Li Z
Pharm Dev Technol; 2024 Feb; 29(2):123-130. PubMed ID: 38327230
[TBL] [Abstract][Full Text] [Related]
7. Nanostructured liquid crystalline formulation as a remarkable new drug delivery system of anti-epileptic drugs for treating children patients.
El-Enin HA; Al-Shanbari AH
Saudi Pharm J; 2018 Sep; 26(6):790-800. PubMed ID: 30202219
[TBL] [Abstract][Full Text] [Related]
8. Phytantriol-based in situ liquid crystals with long-term release for intra-articular administration.
Chen Y; Liang X; Ma P; Tao Y; Wu X; Wu X; Chu X; Gui S
AAPS PharmSciTech; 2015 Aug; 16(4):846-54. PubMed ID: 25573438
[TBL] [Abstract][Full Text] [Related]
9. Bioavailability and Antidiabetic Activity of Gliclazide-Loaded Cubosomal Nanoparticles.
Nasr M; Almawash S; Al Saqr A; Bazeed AY; Saber S; Elagamy HI
Pharmaceuticals (Basel); 2021 Aug; 14(8):. PubMed ID: 34451883
[TBL] [Abstract][Full Text] [Related]
10. Etodolac transdermal cubosomes for the treatment of rheumatoid arthritis: ex vivo permeation and in vivo pharmacokinetic studies.
Salah S; Mahmoud AA; Kamel AO
Drug Deliv; 2017 Nov; 24(1):846-856. PubMed ID: 28535740
[TBL] [Abstract][Full Text] [Related]
11. A short review on the applicability and use of cubosomes as nanocarriers.
Palma AS; Casadei BR; Lotierzo MC; de Castro RD; Barbosa LRS
Biophys Rev; 2023 Aug; 15(4):553-567. PubMed ID: 37681099
[TBL] [Abstract][Full Text] [Related]
12. Travoprost Liquid Nanocrystals: An Innovative Armamentarium for Effective Glaucoma Therapy.
El-Gendy MA; Mansour M; El-Assal MIA; Ishak RAH; Mortada ND
Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986814
[TBL] [Abstract][Full Text] [Related]
13. A polytherapy based approach to combat antimicrobial resistance using cubosomes.
Lai X; Han ML; Ding Y; Chow SH; Le Brun AP; Wu CM; Bergen PJ; Jiang JH; Hsu HY; Muir BW; White J; Song J; Li J; Shen HH
Nat Commun; 2022 Jan; 13(1):343. PubMed ID: 35039508
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of
Farag DBE; Yousry C; Al-Mahallawi AM; El-Askary HI; Meselhy MR; AbuBakr N
Drug Deliv; 2022 Dec; 29(1):62-74. PubMed ID: 34964423
[TBL] [Abstract][Full Text] [Related]
15. Liquid Crystalline Phases for Enhancement of Oral Bioavailability.
Zhang X; Wu W
AAPS PharmSciTech; 2021 Feb; 22(3):81. PubMed ID: 33619612
[TBL] [Abstract][Full Text] [Related]
16. Solubility and Bioavailability Enhancement of Oridonin: A Review.
Zhang Y; Wang S; Dai M; Nai J; Zhu L; Sheng H
Molecules; 2020 Jan; 25(2):. PubMed ID: 31947574
[TBL] [Abstract][Full Text] [Related]
17. Mathematical Modeling of Release Kinetics from Supramolecular Drug Delivery Systems.
Mircioiu C; Voicu V; Anuta V; Tudose A; Celia C; Paolino D; Fresta M; Sandulovici R; Mircioiu I
Pharmaceutics; 2019 Mar; 11(3):. PubMed ID: 30901930
[TBL] [Abstract][Full Text] [Related]
18. Novel in situ gelling vaginal sponges of sildenafil citrate-based cubosomes for uterine targeting.
Aboud HM; Hassan AH; Ali AA; Abdel-Razik AH
Drug Deliv; 2018 Nov; 25(1):1328-1339. PubMed ID: 29869515
[TBL] [Abstract][Full Text] [Related]
19. Folic Acid-Targeted Etoposide Cubosomes for Theranostic Application of Cancer Cell Imaging and Therapy.
Tian Y; Li JC; Zhu JX; Zhu N; Zhang HM; Liang L; Sun L
Med Sci Monit; 2017 May; 23():2426-2435. PubMed ID: 28529305
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
